• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者恶性胸腔和腹腔积液的腔内治疗

Intracavitary treatment of malignant pleural and peritoneal effusions in cancer patients.

作者信息

Gebbia N, Mannino R, Di Dino A, Maxhouni L, Bellone N, Cinque L, Liuzza A, La Motta P, Cannata G, Gulotta G

机构信息

Chair of Chemotherapy, University of Palermo, Italy.

出版信息

Anticancer Res. 1994 Mar-Apr;14(2B):739-45.

PMID:7516642
Abstract

Authors present a review of the intracavitary treatment of malignant effusions in cancer patients, experience with tetracycline, mechloretamine, quinacrine, radio-isotopes, interferon beta and interferon alpha are reviewed. Personal experience with interferon alpha is reported.

摘要

作者对癌症患者恶性积液的腔内治疗进行了综述,回顾了四环素、氮芥、喹吖因、放射性同位素、β干扰素和α干扰素的治疗经验。报告了作者使用α干扰素的个人经验。

相似文献

1
Intracavitary treatment of malignant pleural and peritoneal effusions in cancer patients.癌症患者恶性胸腔和腹腔积液的腔内治疗
Anticancer Res. 1994 Mar-Apr;14(2B):739-45.
2
Management of malignant pleural effusion.恶性胸腔积液的管理
J Surg Oncol. 1978;10(4):361-8. doi: 10.1002/jso.2930100411.
3
Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.α-干扰素局部免疫疗法治疗转移性胸腔和腹腔积液:与免疫参数的相关性
Anticancer Res. 1996 Nov-Dec;16(6B):3855-60.
4
Intracavitary beta-interferon for the management of pleural and/or abdominal effusions in patients with advanced cancer refractory to chemotherapy.
In Vivo. 1991 Nov-Dec;5(6):579-81.
5
Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2.
Support Care Cancer. 1995 Jan;3(1):78-80. doi: 10.1007/BF00343925.
6
An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavity bleomycin.
Cancer. 1986 Feb 15;57(4):721-7. doi: 10.1002/1097-0142(19860215)57:4<721::aid-cncr2820570407>3.0.co;2-5.
7
Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study.
J Surg Oncol. 1987 Oct;36(2):81-3. doi: 10.1002/jso.2930360202.
8
Diagnosis and treatment of malignant pleural effusion.恶性胸腔积液的诊断与治疗
Semin Oncol. 1985 Mar;12(1):54-75.
9
Intracavitary bleomycin vs interferon in the management of malignant pleural effusions.
Chest. 1998 Apr;113(4):1145-6. doi: 10.1378/chest.113.4.1145.
10
Correctable complications of neoplastic disease. 3. Neoplastic effusions.
Conn Med. 1971 Jun;35(6):411-2.

引用本文的文献

1
Switching off malignant pleural effusion formation-fantasy or future?阻断恶性胸腔积液的形成——幻想还是未来?
J Thorac Dis. 2015 Jun;7(6):1009-20. doi: 10.3978/j.issn.2072-1439.2015.05.20.
2
Treatment of malignant ascites.恶性腹水的治疗
Curr Treat Options Oncol. 2008 Jun;9(2-3):215-33. doi: 10.1007/s11864-008-0068-y. Epub 2008 Sep 6.